2016
DOI: 10.18203/2320-6012.ijrms20160020
|View full text |Cite
|
Sign up to set email alerts
|

Risk of premature luteinization in IVF cycles and its impact on clinical pregnancy rate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…[17] As per the latest Indian study, PL (>1.5 ng/ml) was noticed in 16% cases in the agonist group and 6% in the antagonist group (p-0.002). [12] The overall incidence of PL in our study was 12.8% without any significant difference between agonist and antagonist protocol. A study by Houmard et al .…”
Section: Discussionmentioning
confidence: 62%
See 1 more Smart Citation
“…[17] As per the latest Indian study, PL (>1.5 ng/ml) was noticed in 16% cases in the agonist group and 6% in the antagonist group (p-0.002). [12] The overall incidence of PL in our study was 12.8% without any significant difference between agonist and antagonist protocol. A study by Houmard et al .…”
Section: Discussionmentioning
confidence: 62%
“…Many studies including a meta-analysis have shown that PL is associated with a decreased probability of pregnancy during IVF. [111213] On the contrary, some previous researchers did not find any significant differences in pregnancy rates during IVF with high- or low-progesterone levels on the day of ovulation trigger. [14] Two recent studies have shown that serum progesterone level on ovulation trigger day did not affect clinical pregnancy rate.…”
Section: Introductionmentioning
confidence: 92%
“…8.3% and 6.8% respectively at p=0.117 (Venetis et al, 2015;Ecochard et al, 2013). Recently, studies on Indians about PL incidence amongagonist and antagonist subgroups were found to be in 16% cases only at p=0.02 level (Choudhary et al, 2016). An observed value of PL occurrence was 13.33% in studied groups but no significant difference was found among agonist and antagonist subgroups.…”
Section: Discussionmentioning
confidence: 80%